AI Data Insight
Latest data shows that U.S. imports of medicinal and pharmaceutical products slid to $59.49 billion in August, a 12.5% decrease quarter-over-quarter, completely erasing the record high ($108.3 billion) set earlier this year due to trade war panic. With the advancement of the "BIOSECURE Act" and supply chain de-risking, the market is currently in a period of intense inventory destocking and procurement hesitation.